Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5642 record(s)

Req # A-2019-000303

Documents and correspondence related to Canadian clinical trials for the drug Mexaform (Ciba Pharmaceuticals) prior to 1980.

Organization: Health Canada

45 page(s)
January 2020

Req # A-2019-000590

Provide all ProServices contracts issued in the National Capital Region for the months of January, February & March 2019.

Organization: Health Canada

328 page(s)
January 2020

Req # A-2019-001678

Records regarding the use of electroconvulsive therapy by Canadian government institutions during the years 2010-2018.

Organization: Health Canada

0 page(s)
January 2020

Req # A-2019-000649

All Records between Health Canada and Canadian Plasma Resources/Exapharma regarding changing the regulation of plasma collection for Canadian Plasma Resources to twice a week. All consultations between Health Canada and Canadian Blood Services and/or Hema-Quebec regarding the regulatory change to allow Canadian Plasma Resources to collect plasma twice a week.

Organization: Health Canada

221 page(s)
January 2020

Req # A-2019-000752

Health Canada Compliance report delivered to CannTrust.

Organization: Health Canada

0 page(s)
January 2020

Req # A-2019-000829

Approved product labels and lists of ingredients for products, each of which was issued a Temporary Marketing Authorization (TMA) on June 12, 2019: Bang Black Cherry Vanilla Energy Drink (TMA 2018-030109); Bang Blue Razz Energy Drink (TMA 2018-030110) and Bang Cherry Blade Lemonade Energy Drink (TMA 2018-030111).

Organization: Health Canada

42 page(s)
January 2020

Req # A-2019-000845

The documents used to support the approval of the calcitonin (salmon) injection (Drug Identification Number (DIN) 02383233) issued to Agila Specialties Private Limited (and subsequently transferred to Mylan Pharmaceuticals ULC in 2014.

Organization: Health Canada

12 page(s)
January 2020

Req # A-2019-000928

Total numbers of Licenses and total grams licensed for Individual Personal Medical Cannabis Production Licenses ( ACMPR) issued by Health Canada. In each of the communities for each of the years: 2017, 2018, 2019.

Organization: Health Canada

1 page(s)
January 2020

Req # A-2019-000521

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-106665-371.

Organization: Health Canada

0 page(s)
January 2020

Req # A-2019-000964

Any Contribution Agreements, initial or supplementary, between Health Canada and the Institute for Safe Medication Practices ("ISMP") pertaining to Health Canada's funding and ISMP's responsibilities related to the Canadian Medication Incident Reporting and Prevention System (CMIRPS) between January 1st, 2003 and August 30th, 2019.

Organization: Health Canada

238 page(s)
January 2020
Date modified: